Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Aug 24, 2025
Date Accepted: May 5, 2026

The final, peer-reviewed published version of this preprint can be found here:

Near–Real-Time Clinical Trial Accrual Dashboard in a National Cancer Institute–Designated Cancer Center: Mixed Methods Implementation Study

Pepper S, Ratnayake I, Mahmudur Rahman M, Islam Talukder MR, Islam Saif MS, Rippee O, Jayawardhana A, Lin T, Streeter N, Gajewski B, Wick J, Mayo M, Mudaranthakam DP

Near–Real-Time Clinical Trial Accrual Dashboard in a National Cancer Institute–Designated Cancer Center: Mixed Methods Implementation Study

JMIR Med Inform 2026;14:e82920

DOI: 10.2196/82920

PMID: 42229883

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Accrual Insights: An R Shiny Application for Optimizing Clinical Trial Tracking and Monitoring in Cancer Centers

  • Sam Pepper; 
  • Isuru Ratnayake; 
  • Mohammod Mahmudur Rahman; 
  • Md Robiul Islam Talukder; 
  • Md Saiful Islam Saif; 
  • Olivia Rippee; 
  • Ananda Jayawardhana; 
  • Tara Lin; 
  • Natalie Streeter; 
  • Byron Gajewski; 
  • Jo Wick; 
  • Matthew Mayo; 
  • Dinesh Pal Mudaranthakam

ABSTRACT

Accurate reporting of clinical trial data is essential for advancing cancer research. Insufficient recruitment often leads to unsuccessful trials. Many institutions have implemented analytical strategies to mitigate the low accrual rates in clinical trials for cancer. The objective of this paper is to explain the process of creating a dashboard and how researchers can visualize trends and key details in the data using the dashboard. The University of Kansas Cancer Center (KUCC) has developed an interactive dashboard to process and disseminate near-real-time data on the tracking and monitoring of clinical trial accruals. Sequential analysis of enrollment data and visualizing past trends could lead to more effective proactive planning and strategies to improve enrollment. The SQL queries behind the dashboard run every morning and identify any data-related discrepancies, which are then reported to the Clinical Trials Office for manual corrections, thereby increasing the validity of the data. This dashboard, a living tool with continuous updates, is an attempt to increase accrual rates and thereby enhance opportunities to manage and complete trials successfully. We linked the data in an Oracle database to a dashboard that displays accrual data categorized by demographic and diversity matrices in tabular, summarized, and graphical formats, providing near-real-time insights for research teams to track progress and make timely, data-driven decisions. The KUCC Accrual dashboard is open only to members of research teams at KUCC. Between May 2022 and May 2025, the KUCC Accrual dashboard logged 1,163 unique sessions, a promising performance. While the KUCC accrual dashboard has potential for improvement, it currently generates feedback of near-real-time accruals, historical trends, and accrual forecasts while supporting data enhancement.


 Citation

Please cite as:

Pepper S, Ratnayake I, Mahmudur Rahman M, Islam Talukder MR, Islam Saif MS, Rippee O, Jayawardhana A, Lin T, Streeter N, Gajewski B, Wick J, Mayo M, Mudaranthakam DP

Near–Real-Time Clinical Trial Accrual Dashboard in a National Cancer Institute–Designated Cancer Center: Mixed Methods Implementation Study

JMIR Med Inform 2026;14:e82920

DOI: 10.2196/82920

PMID: 42229883

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.